Related Experiment Video
Updated: Jul 9, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Personalized therapy in chronic viral hepatitis
Maurizia Rossana Brunetto1, Piero Colombatto, Ferruccio Bonino
1Gastroenterology and Hepatology Unit, University Hospital of Pisa, Via Paradisa 2, 56124 Cisanello, Pisa, Italy. brunetto@med-club.com
Molecular Aspects of Medicine
|December 11, 2007
Summary
Identifying at-risk hepatitis B and C virus carriers is crucial for preventing progressive liver disease. Personalized antiviral therapy, combining molecular biology and bio-mathematical modeling, offers a promising approach for effective treatment.
Area of Science:
- Hepatology
- Virology
- Computational Biology
Background:
- Chronic hepatitis B (HBV) and C (HCV) affect over 600 million people globally.
- A significant percentage of carriers are at risk for severe liver disease and life-threatening lesions.
- Accurate identification of at-risk individuals is essential to prevent disease progression and inappropriate treatments.
Purpose of the Study:
- To review the potential of personalized antiviral therapy for chronic hepatitis B and C.
- To highlight the limitations of traditional statistical methods in managing complex host-virus interactions.
- To introduce the combined use of molecular biology and bio-mathematical modeling for optimizing treatment decisions.
Main Methods:
- Review of current literature on hepatitis B and C management.
- Discussion of the principles of personalized medicine in antiviral therapy.
- Exploration of bio-mathematical modeling for tracking viral dynamics during treatment.
Main Results:
- Standard statistical approaches are insufficient for complex host-virus interactions in chronic hepatitis.
- Personalized antiviral therapy requires consideration of individual variability, host/virus interplay, and drug resistance.
- Molecular biology combined with bio-mathematical modeling can aid clinical decision-making.
Conclusions:
- A personalized approach is necessary for effective management of chronic hepatitis B and C.
- Bio-mathematical modeling offers a dynamic tool for monitoring viral infection during therapy.
- This integrated approach has the potential to improve treatment outcomes and reduce ineffective therapies.
Related Concept Videos
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...